Antiviral Agents Bulletin
The Antiviral Agents Bulletin is the only periodical specializing in antiviral drug and vaccine development. The Bulletin covers all antiviral therapeutics, but the largest portion of news articles, patents, etc., concern HIV and AIDS-related antiviral drugs and vaccines.
Articles in the Antiviral Agents Bulletin describe and assess commercial and scientific developments, federal and regulatory activities, information resources, treatment advances and trends, patents and technology transfers. Abstracts for antiviral and virus-related U.S. patents and international patent disclosures are also provided. An annual review issue describes the year's major developments and indexes articles by agent, virus/disease and organization. U.S. patents are indexed in another issue.
Ordering information - Subscriptions are $350 for 12 monthly issues (32 pages each). ($410 for non-North
American subscribers, issues sent by air mail).
Contact the the Biotechnology
Information Institute by E-mail or otherwise for free sample issues and further information.
Online Access/Vendors - - The full text of the Bulletin is online at this Web site. Individual, site and company-wide Web database subscriptions are available. Subscribers may also choose to load the database on their own PC(s) or network(s), receive it on CD-ROM, etc.
Biotechnology Information Institute
Publisher of:
Copyright ©2001. Biotechnology Information Institute